|
A modeling-based biopharmaceutical company, Optimata provides comprehensive solutions, navigating drug development through shorter, safer pathways towards a high market competitive profile.
Expert in predictive biosimulation, Optimata mathematically models patient physiological and pathological processes, along with the dynamics of drug-patient interactions, with a special focus on cancer and oncology drugs.
Simulated by Optimata Virtual Patient software, these models provide valuable drug effect predictions, with recommendations of optimal treatment regimens per clinical indication and patient population. | | Optimata's technology enables:
-
Drug repurposing
-
Enhanced drug competitive profile
-
Early "GO/NO-GO" development decisions
-
Drug safety profile
-
Optimal dosing schedules
-
Clinical indication selection/expansion
Optimata offers a powerful, interactive, clinical trial optimization tool, enabling huge reductions in time-to-market and development costs. |
